Larvol Delta - A-Study-of-Oral-IRAK4-Inhibitor-CA4948-in-Combination-With-Pembrolizumab-Following-Stereotactic-Radiosurgery-in-Patients-With-Melanoma-Brain-Metastases

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05669352

Jan 1, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next